CYTOKINETICS, INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.4 USD | +0.87% |
|
-10.62% | -30.12% |
| 09/05 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
| 08/05 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Bio Therapeutic Drugs | +0.79% | -10.62% | -30.12% | +49.79% | +459.40% | 607Cr |  |  | |
- Stock Market
- Equities
- CYTK Stock
- Charts Cytokinetics, Incorporated
- Relative Strength Chart